CTOs on the Move

Columbus Regional Healthcare System

www.crhs.net

 
As the region`s leading provider of health care, Columbus Regional Health has touched the lives of most of the children and adults in this region through its comprehensive network of services.   Located in the West Georgia city of Columbus, Columbus Regional Health was established in 1986 as a not-for-profit health services organization, but its roots can be traced back to 1836 when the local hospital was a small wooden building on the banks of the Chattahoochee River.
  • Number of Employees: 10K-50K
  • Annual Revenue: $500M-1 Billion
  • www.crhs.net
  • 710 Center St
    Columbus, GA USA 31901
  • Phone: 706.571.1000

Executives

Name Title Contact Details

Similar Companies

BluMetric

BluMetric is a new company built on a proud past. Its five originating operating companies, WESA, WESAtech, Envir-Eau, OEL-HydroSys, and Seprotech, are internationally known for cutting-edge work in the fields of water/wastewater treatment and professional environmental services. Our combined staff of approximately 170 scientists, engineers, industrial hygienists, environmental auditors, project managers, financial management specialists and support personnel are uniquely equipped to undertake environmental projects of any size, in any industry. Innovation, agility and client-responsive service are our hallmarks.

LaserStim

LaserStim is a Plano, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mcmahon Group

Mcmahon Group is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Long Beach Medical Center

Long Beach Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Long Beach, NY. To find more information about Long Beach Medical Center, please visit www.lbmc.org

MSI

MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).